Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company, is devoted to enhancing existing pharmaceutical products. To date, the company has brought two products to market and has developed a pipeline with late-stage product opportunities designed to address common medical conditions. Depomed’s core delivery technology, AcuForm, is a patented, polymer-based technology that improves delivery through gastric retention. For further information, visit the Company’s web site at www.depomedinc.com.
- 18 years ago
QualityStocks
Depomed, Inc. (NASDAQ: DEPO)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) to Attend SOF Week 2026
This article has been disseminated on behalf of SPARC AI Inc. and may include paid…
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Appoints VP Exploration And VP Mining Operations
This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.…
-
QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine
NRx Pharmaceuticals (NASDAQ: NRXP) announced it has initiated its first commercial manufacturing order of preservative-free…